MSRA
Basic information
Region (hg38): 8:10054292-10428891
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MSRA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 26 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 28 | 3 | 1 |
Variants in MSRA
This is a list of pathogenic ClinVar variants found in the MSRA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-10054520-C-G | not specified | Uncertain significance (Nov 09, 2023) | ||
8-10054532-C-T | not specified | Uncertain significance (Nov 30, 2021) | ||
8-10054539-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
8-10054547-C-T | not specified | Uncertain significance (May 30, 2023) | ||
8-10054556-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
8-10054582-G-C | not specified | Uncertain significance (Jul 14, 2022) | ||
8-10054634-C-G | not specified | Uncertain significance (Dec 28, 2022) | ||
8-10054643-C-G | not specified | Uncertain significance (Sep 14, 2023) | ||
8-10207815-CTT-C | MSRA-related disorder | Likely benign (May 22, 2019) | ||
8-10207841-C-G | not specified | Uncertain significance (Dec 28, 2022) | ||
8-10207841-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
8-10207874-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
8-10207893-C-A | not specified | Uncertain significance (Dec 13, 2023) | ||
8-10245133-A-C | not specified | Uncertain significance (Jan 09, 2024) | ||
8-10245167-A-C | not specified | Uncertain significance (Apr 25, 2022) | ||
8-10245168-A-G | MSRA-related disorder | Uncertain significance (Oct 03, 2022) | ||
8-10245172-G-A | Likely benign (Apr 11, 2018) | |||
8-10245191-C-G | not specified | Uncertain significance (Oct 04, 2022) | ||
8-10301561-G-A | not specified | Uncertain significance (Apr 22, 2022) | ||
8-10301574-G-C | not specified | Uncertain significance (Nov 21, 2023) | ||
8-10301625-C-G | not specified | Uncertain significance (Sep 29, 2022) | ||
8-10301626-G-C | not specified | Uncertain significance (Oct 13, 2023) | ||
8-10319888-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
8-10319942-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
8-10428162-C-T | MSRA-related disorder | Likely benign (Dec 09, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MSRA | protein_coding | protein_coding | ENST00000317173 | 6 | 374624 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.53e-15 | 0.000945 | 125566 | 0 | 182 | 125748 | 0.000724 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.63 | 221 | 135 | 1.64 | 0.00000733 | 1510 |
Missense in Polyphen | 76 | 53.832 | 1.4118 | 610 | ||
Synonymous | -3.37 | 88 | 56.0 | 1.57 | 0.00000357 | 439 |
Loss of Function | -1.62 | 19 | 12.7 | 1.49 | 6.26e-7 | 145 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00161 | 0.00154 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000937 | 0.0000924 |
European (Non-Finnish) | 0.00131 | 0.00117 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000271 | 0.000261 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Has an important function as a repair enzyme for proteins that have been inactivated by oxidation. Catalyzes the reversible oxidation-reduction of methionine sulfoxide in proteins to methionine.;
- Pathway
- Sulindac Metabolic Pathway;Methionine De Novo and Salvage Pathway;Metabolism of proteins;Protein repair
(Consensus)
Recessive Scores
- pRec
- 0.337
Intolerance Scores
- loftool
- 0.169
- rvis_EVS
- -0.96
- rvis_percentile_EVS
- 9.09
Haploinsufficiency Scores
- pHI
- 0.0900
- hipred
- N
- hipred_score
- 0.318
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.507
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Msra
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- cellular protein modification process;methionine metabolic process;response to oxidative stress;protein repair;cellular response to oxidative stress;oxidation-reduction process
- Cellular component
- nucleoplasm;cytoplasm;mitochondrion;cytosol;actin cytoskeleton;membrane;extracellular exosome
- Molecular function
- peptide-methionine (S)-S-oxide reductase activity;L-methionine-(S)-S-oxide reductase activity